The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration …
B Haeberle, A Rangaswami, M Krailo… - Pediatric blood & …, 2020 - Wiley Online Library
Purpose Treatment outcomes for hepatoblastoma have improved markedly in the
contemporary treatment era, principally due to therapy intensification, with overall survival …
contemporary treatment era, principally due to therapy intensification, with overall survival …
The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration …
B Haeberle, A Rangaswami… - … blood & cancer, 2020 - digitalcommons.providence.org
PURPOSE: Treatment outcomes for hepatoblastoma have improved markedly in the
contemporary treatment era, principally due to therapy intensification, with overall survival …
contemporary treatment era, principally due to therapy intensification, with overall survival …
The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration …
B Haeberle, A Rangaswami, M Krailo… - Pediatric Blood & …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Purpose</jats: title>< jats: p>
Treatment outcomes for hepatoblastoma have improved markedly in the contemporary …
Treatment outcomes for hepatoblastoma have improved markedly in the contemporary …
The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration …
B Haeberle, A Rangaswami, M Krailo… - Pediatric blood & …, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose Treatment outcomes for hepatoblastoma have improved markedly in the
contemporary treatment era, principally due to therapy intensification, with overall survival …
contemporary treatment era, principally due to therapy intensification, with overall survival …
The importance of age as prognostic factor for the outcome of patients with hepatoblastoma. Analysis from the Children's Hepatic tumors International Collaboration …
B Haeberle, A Rangaswami, M Krailo… - PEDIATRIC BLOOD & …, 2020 - iris.uniroma1.it
Purpose: Treatment outcomes for hepatoblastoma have improved markedly in the
contemporary treatment era, principally due to therapy intensification, with overall survival …
contemporary treatment era, principally due to therapy intensification, with overall survival …
The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration …
B Haeberle, A Rangaswami, M Krailo… - PEDIATRIC BLOOD & …, 2020 - research.unipd.it
Purpose: Treatment outcomes for hepatoblastoma have improved markedly in the
contemporary treatment era, principally due to therapy intensification, with overall survival …
contemporary treatment era, principally due to therapy intensification, with overall survival …
The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration …
B Haeberle, A Rangaswami, M Krailo… - Pediatric Blood & …, 2020 - epub.ub.uni-muenchen.de
Purpose: Treatment outcomes for hepatoblastoma have improved markedly in the
contemporary treatment era, principally due to therapy intensification, with overall survival …
contemporary treatment era, principally due to therapy intensification, with overall survival …
The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration …
B Haeberle, A Rangaswami, M Krailo… - Pediatric blood & …, 2020 - sonar.ch
METHODS We evaluated 1605 patients with hepatoblastoma included in the CHIC
database to assess the relationship between event-free survival (EFS) and age at diagnosis …
database to assess the relationship between event-free survival (EFS) and age at diagnosis …
The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration …
B Haeberle, A Rangaswami, M Krailo… - Pediatric blood & …, 2020 - folia.unifr.ch
METHODS We evaluated 1605 patients with hepatoblastoma included in the CHIC
database to assess the relationship between event-free survival (EFS) and age at diagnosis …
database to assess the relationship between event-free survival (EFS) and age at diagnosis …
The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration …
B Haeberle, A Rangaswami, M Krailo… - Pediatric Blood & …, 2020 - europepmc.org
PURPOSE: Treatment outcomes for hepatoblastoma have improved markedly in the
contemporary treatment era, principally due to therapy intensification, with overall survival …
contemporary treatment era, principally due to therapy intensification, with overall survival …